News

AbbVie launches first ever series of mindfulness podcasts to support people living with blood cancers

PRESS RELEASE

AbbVie launches first ever series of mindfulness podcasts to support people living with blood cancers

 

  • In collaboration with AbbVie, mindfulness expert Dr Caroline Hoffman has developed a series of new podcast audio recordings specifically tailored to help support people living with blood cancers, and their partners or carers

2016 CLLSA Glasgow Members Meeting

There were 4 medical presentations: two given by
Dr Alison McCraig Affiliate (Paul O'Gorman Leukaemia Research Centre) Glasgow University

as well as presentations by

Dr Emilio Cosimo Research Associate (Paul O'Gorman Leukaemia Research Centre) Glasgow University
Dr Ailsa Holroyd Clinical Research Fellow (Institute of Cancer Sciences) Glasgow University.

The presentations can be found here

European Medical Agency - Rixathon

European Medical Agency - On 21 April 2017, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Rixathon, intended for the treatment of non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukaemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).

Bloodwise Patient Need Survey

As you may have seen Bloodwise have recently launched a survey to help ensure that all blood cancer patients have access to services that help them live well with and beyond their cancer. They are starting by looking to identify any gaps in the current Cancer Recovery Package, understanding levels of awareness and usage of the package.